![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 21, 2015 4:51:49 PM
Here's an email response to a friend that recently bought and has been asking similar question about Leos PR skills and if he should outsource it:
Maybe. Leo is in the driver seat right now which scares some people. Not me though. It's strictly because of that that CTIX was able to purchase PYMX (Brilacidin) out of chapter 11 for what amounts to pennies.
Big pharma has to have a lot of people sign off before they make a move like that. We paid 5 million for a multi billion dollar platform. This will be written about in Biotech lore soon.
Kev is still early in clinicals and we've had squat for data released. Dana Farber is notoriously tight lipped. Hence the reason why they are THE place to go in oncology trials.
Holy crap! Do I gush enough about this company?
Last week was a pure shakeout. Sucks to be anyone who sold, unless they got right back in.
Uplisting will happen, and when it does, it will be spectacular. The further we advance trials, quietly, on our own, the more valuable an asset we become to potential suitors. That would almost be a shame. I read someone on the board put a 100 billion dollar valuation on the company if the big three pan out. Talk about castles in the sky. It's not that absurd though.
Every move Leo makes seems calculated and aimed at protecting shareholder value. Why are there so many people that remain skeptical of a finance professional who has steered us from pennies to almost $5? Once again, too many people not satisfied when they damn well should be.
"Kill your doubt, with the coldest of weapons, confidence."
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM